Bioventix Share Discussion Threads

[boros10] 10/5/2017 11:29

I am also assuming at least 83p EPS for the current year.

[stepone68] 10/5/2017 11:25

EPS was 68p last year, so a 40% increase would be around 95p - not 115. I'm looking for 83p eps this year, based on £6.6m turnover. Current broker forecasts are for 79p, so I don't think there is any no way they'll break a pound this year, never mind 115.

That would leave them on a PE of around 22-25 for 2017, which is still cheap for a company growing sales at the rate they are.

StepOne

[hydrus] 10/5/2017 10:41

Net profits were up 40% for half year. If they maintain this for the full year that would lead to EPS circa 115p. So currently on a PE ratio of about 16.Considering the potential gap in revenue next year appears to have gone away, plus the extremely high quality nature of the business, it seems very cheap.

[igbertsponk] 10/5/2017 10:30

The new high in the price made me smile!

[panic investor] 10/5/2017 10:14

That made me smile !

[stepone68] 10/5/2017 09:23

RNS out at 9am - doesn't say much though ...

[ilovefrogs] 10/5/2017 09:23

RNS now out. Not very informative though.....

[gsbmba99] 10/5/2017 08:44

I think Roche and Abbott HS-Troponin assays have been approved in Europe since Autumn 2014 (might have been earlier). Roche received FDA approval in Jan 17 (having applied in Oct 16). This Medscape article from Jan 17 ( says "a high-sensitivity troponin I assay from Abbott Laboratories currently under FDA review and used globally except for the US and another from Siemens expected to be submitted in the coming months." That suggests that Abbott had already filed in January. If true, they are running behind Roche's 3 months from filing to clearance. Also suggests reasonable chance of Siemens filing for FDA approval this year if "expected to be submitted in the coming months" holds true.

[hydrus] 10/5/2017 08:28

From the last results RNS:'Whilst the exact timing of a Siemens product launch is confidential Siemens information and will be dependent on their discussions with global regulatory authorities, the Board expects to hear news later in 2017 relating to their ex-US activities. Significant troponin revenues during the financial year 2017/2018 are expected to offset the loss of revenues of around £800,000 from another product due to the expiry of the relevant agreement.'Therefore expected that this launch would not include US. Looks like 2017/18 de-risked due to the news.

[igbertsponk] 10/5/2017 08:23

looking at the twitter thread, seems US launch always a year behind elsewhere.

[gsbmba99] 10/5/2017 08:11

Thanks. Is there comment on how broad the launch is? I am assuming this is following on from CE mark approval and therefore Europe plus any other countries that accept CE mark.

[boros10] 10/5/2017 08:06

FinnCap issued a short note this morning confirming the Siemen's news and suggesting a revised price target of £19.25. Peter had said the Siemen launch would be announceable so unclear why no RNS as yet.

[gsbmba99] 10/5/2017 07:59

No RNS this morning. I was under the impression Company considered Troponin launch RNSable. Leon Boros comment on Twitter yesterday ( Apad, did you get a response from the company?

[apad] 09/5/2017 11:08

Thanks, g

Copied to the VLG board.

apad

[gsbmba99] 09/5/2017 10:44

Noteworthy press release from Siemens yesterday ( It would appear that the high sensitivity Troponin test is now available on Advia Centaur XPT and Advia Centaur XP in some countries outside the US. "Siemens Healthineers announced today the availability of its new high-sensitivity troponin I (TNIH)1 in vitro diagnostics assay, designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma." Footnote 1 says: "Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements."

[gsbmba99] 27/4/2017 12:05

Inven2, the Norwegian business incubator owned by the University of Oslo and Oslo University Hospital has an update on Pre-Diagnostics on its website ( Paraphrasing from a translation: If everything goes according to plan, the first version of their test will be ready for clinical trials during the year. They have a prototype from Thermo Fisher ready but they are working on increasing test specificity by developing better antibodies that are specific to the actual peptides in the protein beta-amyloid. Aiming for funding from EU Horizon 2020 program.

[gsbmba99] 27/4/2017 11:45

The Pre-Diagnostics website ( says that the United States Patent & Trademark Office has issued a Notice of Allowance for the first patent (DIAGNOSTIC METHOD) in Jan 17. It looks like this patent is in place as of 17 Apr 17. The patent number is 9,625,474. You can get the full text by entering the patent number here ( No idea how strong or valuable it is but certainly better than no patent.

[gsbmba99] 21/4/2017 11:45

Interesting video discussing the high-sensivity troponin test. It does a pretty good job of explaining the value of the test especially in comparison to the previous generation and the implications of a positive test (since most people will have a positive result). The site is free but requires registration. ( The second slide for "Case" has a footnote that says that high sensitivty Troponin testing is not yet available in the US but was FDA approved in January (video dated 17 Apr 17). If true, we're three months after approval with no commercial launch yet. It also appears Roche is not allowed to call it a high sensitivity test (at least in the US) but has to refer to it as a next generation test (

[lancasterbomber] 21/4/2017 09:41

Heading back to 1800

[igbertsponk] 20/4/2017 10:12

That's a tad better.

[ilovefrogs] 12/4/2017 17:50

It's a relatively sharp fall, but this stock tends to go up 50-60% around results season and then retrace 20% ready for the next wave. Hopefully, this is just a continuation of that trend. If it goes back to the £15 level, I'll be buying some more!

[sharw] 12/4/2017 16:51

xd was last week (the date of Lauders post) when the mid dropped from 1800 to 1775

[pyemckay] 12/4/2017 16:37

its been on a tear recently so i'm not overly concerned. take a chill pill